Explore

Trump Administration Plans to End Medicare Drug Plan Subsidy, Affecting Premium Costs

Trump Administration Plans to End Medicare Drug Plan Subsidy, Affecting Premium Costs

The Trump administration has announced plans to terminate a subsidy program that has been instrumental in keeping premiums for Medicare drug plans affordable. According to the Wall Street Journal, the program, which is expected to provide insurers with approximately $3.6 billion in subsidies this year, will not be renewed beyond 2026. Medicare Part D, which offers prescription drug coverage to millions of Medicare beneficiaries through private insurance plans, is a crucial component of the federal health program for seniors. Rising healthcare costs are a significant concern in the U.S., especially for older Americans living on fixed incomes. Nearly 25 million people were enrolled in standalone Medicare Part D prescription drug plans in 2026, as reported by the health policy research group KFF. An administration official stated that the subsidies encouraged insurers to raise premiums, as the government absorbed much of the added cost. The official also mentioned that other measures aimed at controlling Medi...

National Grassroots Movement Launches Campaign Against Rising U.S. Healthcare Costs

National Grassroots Movement Launches Campaign Against Rising U.S. Healthcare Costs

A new grassroots movement, 'One Nation, Overcharged,' has been launched to address the escalating costs of healthcare in the United States. The campaign, supported by the Robert Wood Johnson Foundation and over 130 advocacy groups, aims to prioritize affordable healthcare over corporate profits. The movement seeks to engage a wide range of participants, including celebrities, community organizers, and civic leaders, to raise awareness and demand systemic changes. The initiative will utilize storytelling, research, and community events to highlight the impact of high healthcare costs on American families, particularly those in marginalized communities.

2027 Maternity Coding Changes Aim to Modernize U.S. Healthcare Billing Practices

2027 Maternity Coding Changes Aim to Modernize U.S. Healthcare Billing Practices

Starting January 1, 2027, the U.S. will implement new maternity care coding and reimbursement practices, marking the first major update in over three decades. Historically, maternity care has been billed through global codes, which cover prenatal visits, delivery, and postpartum care as a single payment. This model is outdated, as modern maternity care often involves multiple healthcare providers. The American Medical Association, in collaboration with other medical societies, has developed new CPT codes to allow for more detailed billing of prenatal care, labor management, delivery, and postpartum care as distinct services. This change aims to better reflect the complexity and diversity of maternity care today.

Medicare Advantage Plan Changes Trigger Special Enrollment Periods for Beneficiaries

Medicare Advantage Plan Changes Trigger Special Enrollment Periods for Beneficiaries

Medicare Advantage beneficiaries receiving letters about plan terminations or significant network changes are granted Special Enrollment Periods (SEPs) to switch plans. When a Medicare Advantage plan does not renew, the Centers for Medicare & Medicaid Services (CMS) provides a Non-Renewal SEP from December 8 to the end of February, allowing beneficiaries to join a different plan or return to Original Medicare. Additionally, a significant network change, such as a hospital leaving the network, may trigger a SEP. Beneficiaries have a 63-day window to secure a Medigap policy without medical underwriting, offering protection against health-based premium increases.

Universal Health Services Faces Financial Strain Due to Surge in Uninsured Patients

Universal Health Services Faces Financial Strain Due to Surge in Uninsured Patients

Universal Health Services (UHS), a major for-profit hospital operator, is experiencing significant financial losses due to a surge in uninsured patients. This development follows the Republican-controlled Congress's decision not to extend enhanced subsidies for health insurance plans under the Affordable Care Act (ACA), leading to a drop in enrollment by about 3 million people. UHS had initially anticipated that patients losing ACA coverage would find alternative insurance, but this has not materialized. As a result, UHS and other hospital systems are facing increased costs from treating uninsured patients who are unable to pay their medical bills. This situation has resulted in lost revenues amounting to hundreds of millions of dollars across the U.S. healthcare system.

National Movement 'One Nation, Overcharged' Demands Affordable U.S. Healthcare

National Movement 'One Nation, Overcharged' Demands Affordable U.S. Healthcare

A new grassroots movement, 'One Nation, Overcharged,' is launching a nationwide campaign to address the rising costs of healthcare in the U.S. The movement, supported by the Robert Wood Johnson Foundation and over 130 advocacy groups, aims to prioritize people over profits in the healthcare system. It seeks to engage a wide range of participants, including celebrities, activists, and community leaders, to advocate for affordable healthcare. The campaign will utilize storytelling, research, and community events to highlight the impact of high healthcare costs and push for systemic change.

Nursing Workforce Faces Retention Crisis Amid Increasing Job Demands

Nursing Workforce Faces Retention Crisis Amid Increasing Job Demands

The U.S. nursing sector is experiencing a retention crisis rather than a shortage of licensed nurses. Despite efforts to increase the number of nursing graduates, many nurses are leaving bedside positions due to demanding work conditions exacerbated by cost-cutting measures in hospitals. These measures include reduced staffing, increased workloads, and the elimination of support roles, leading to burnout and job dissatisfaction. The pandemic has intensified these challenges, with nurses reporting increased responsibilities without corresponding resources, contributing to high turnover rates in the profession.

Trump Administration Ends Medicare Drug Premium Subsidy, Impacting Millions

Trump Administration Ends Medicare Drug Premium Subsidy, Impacting Millions

The Trump administration has announced the termination of a subsidy program designed to stabilize premiums for Medicare prescription drug plans after 2026. The Centers for Medicare & Medicaid Services (CMS) stated that insurers have gained sufficient experience with Medicare Part D to price their plans accurately without the need for government support. CMS Administrator Dr. Mehmet Oz noted that premiums will increase by less than $10 for most Medicare recipients, with some potentially seeing lower premiums. Medicare Part D is a crucial component of the federal health program, providing prescription drug coverage to millions of beneficiaries through private insurance plans. In 2026, nearly 25 million people were enrolled in standalone Medicare Part D drug plans, according to the Kaiser Family Foundation.

Federal Court Halts Key 2027 ACA Marketplace Rule Changes Affecting Insurance Market

Federal Court Halts Key 2027 ACA Marketplace Rule Changes Affecting Insurance Market

A federal judge in Maryland has issued a stay on eight provisions of the 2027 Notice of Benefit and Payment Parameters Final Rule, which aimed to implement significant changes to the Affordable Care Act (ACA) individual insurance market. The court found that the U.S. Department of Health and Human Services (HHS) likely exceeded its authority or failed to justify the changes. The provisions in question were expected to reduce enrollment, increase premiums, and raise out-of-pocket costs for some consumers. The case, City of Columbus et al. v. Kennedy et al., challenges the HHS's authority under the ACA, which has been a subject of continuous litigation since its enactment in 2010.

National Academy of Medicine Highlights Misaligned Financial Incentives in U.S. Health Care System

National Academy of Medicine Highlights Misaligned Financial Incentives in U.S. Health Care System

The National Academy of Medicine has released a discussion paper addressing the misalignment of financial incentives within the U.S. health care system. The paper identifies three core drivers of financial misalignment and proposes 12 action levers to address these issues. The current system heavily relies on fee-for-service payments, which incentivize the provision of more services rather than focusing on health outcomes. The paper suggests that aligning payment incentives across public and private payers, expanding flexibility in health spending policies, and establishing global cost mechanisms could improve efficiency and effectiveness. The discussion also highlights the need for a coordinated national approach to health system performance, emphasizing the importance of prevention and community-based health improvements.

Nonprofit Healthcare Groups Face Increased Pressure Amid Rising Costs

Nonprofit Healthcare Groups Face Increased Pressure Amid Rising Costs

A recent study by the West Health-Gallup Center on Healthcare in America reveals that fewer than half of Americans can consistently afford healthcare, intensifying the strain on nonprofit healthcare organizations. The study, conducted between October and December 2025, shows that only 49% of U.S. adults are classified as 'Cost Secure,' meaning they can afford quality care and necessary medications. This marks a decline from 56% in 2021. The study highlights significant disparities among racial groups, with only 38% of Black adults and 32% of Hispanic adults being Cost Secure, compared to 55% of White adults. The findings indicate a growing challenge for nonprofit healthcare providers as more Americans struggle to afford healthcare.

CMS Proposes New Guidance for Medicare Drug Price Negotiation Program

CMS Proposes New Guidance for Medicare Drug Price Negotiation Program

The Centers for Medicare & Medicaid Services (CMS) has released draft guidance for the implementation of the Maximum Fair Price (MFP) in 2028 under the Medicare Drug Price Negotiation Program. This guidance, published on July 16, 2026, is part of the ongoing efforts to manage drug pricing under the Inflation Reduction Act. CMS is seeking public comments on this draft, with a deadline set for September 18, 2026. The proposed rule also includes changes to the Part D inflation rebate program, such as defining the 'first marketed date' for drugs. Additionally, the 2027 Physician Fee Schedule proposed rule requires 340B covered entities to submit Part D claims data, aiming to improve the accuracy of rebate calculations.